申请人:UCB BIOPHARMA SPRL
公开号:US20160297799A1
公开(公告)日:2016-10-13
A series of substituted benzotriazole derivatives, being potent modulators of various human ailments, including autoimmune and inflammatory disorders; neurological and neurodegenerative disorders; pain and nociceptive disorders; cardiovascular disorders; metabolic disorders; ocular disorders; and oncological disorders.